Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRTG

Portage Biotech (PRTG) Stock Price, News & Analysis

Portage Biotech logo

About Portage Biotech Stock (NASDAQ:PRTG)

Key Stats

Today's Range
N/A
50-Day Range
$6.81
$9.97
52-Week Range
N/A
Volume
377,941 shs
Average Volume
56,380 shs
Market Capitalization
$8.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRTG Stock News Headlines

Melt-up warning
Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in his urgent broadcast, he names three investments he believes could soar as America’s financial system nears a breaking point.tc pixel
PRTG Portage Biotech Inc. - Seeking Alpha
See More Headlines

PRTG Stock Analysis - Frequently Asked Questions

Portage Biotech Inc. (NASDAQ:PRTG) released its quarterly earnings results on Tuesday, November, 26th. The company reported ($1.26) earnings per share (EPS) for the quarter.

Shares of Portage Biotech reverse split on the morning of Thursday, August 15th 2024.The 1-20 reverse split was announced on Tuesday, August 13th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, August 14th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Portage Biotech investors own include Meta Platforms (META), Alimera Sciences (ALIM), Angion Biomedica (ANGN), AirMedia Group (ANTE), Broadcom (AVGO), Barnwell Industries (BRN) and Crescent Biopharma (CBIO).

Company Calendar

Last Earnings
11/26/2024
Today
10/18/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PRTG
CIK
1095435
Fax
N/A
Employees
6
Year Founded
1973

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.02
Quick Ratio
2.02

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.79) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,050,000
Free Float
608,000
Market Cap
$8.01 million
Optionable
Optionable
Beta
0.25
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:PRTG) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners